US2807644A
(en)
|
1954-08-20 |
1957-09-24 |
Parke Davis & Co |
Pantethine inhibitors
|
DE1205972B
(en)
|
1963-08-20 |
1965-12-02 |
Merck Ag E |
Process for the production of a lipoic acid derivative
|
US4011342A
(en)
|
1971-06-02 |
1977-03-08 |
Seperic |
Method and composition for the treatment of hypertension with ortho-disubstituted arylguanidines
|
GB1356470A
(en)
|
1971-06-02 |
1974-06-12 |
Seperic |
Ortho-disubstituted aryl-guanidines process for their preparation and applications thereof
|
AU514991B2
(en)
|
1976-05-26 |
1981-03-12 |
Commonwealth Of Australia, The |
Pharmaceutical compositions containing antiinflammatory analgesic compounds
|
JPS5412340A
(en)
|
1977-06-27 |
1979-01-30 |
Daito Koeki |
Process for preparing phenylacetate derivative
|
JPS5677259A
(en)
|
1979-11-29 |
1981-06-25 |
Nippon Chemiphar Co Ltd |
N-pyridoxyl 5,8,11,14,17-eicosapentaenoic acid amide, and its preparation
|
JPS57500432A
(en)
|
1980-03-20 |
1982-03-11 |
|
|
US4404366A
(en)
|
1980-05-06 |
1983-09-13 |
Miles Laboratories, Inc. |
Beta-galactosyl-umbelliferone-labeled hapten conjugates
|
US4412992A
(en)
|
1980-07-21 |
1983-11-01 |
Biorex Laboratories Limited |
2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
|
US4440763A
(en)
|
1981-03-18 |
1984-04-03 |
Block Drug Company, Inc. |
Use of 4-aminosalicyclic acid as an anti-inflammatory agent
|
IT1190727B
(en)
|
1982-03-10 |
1988-02-24 |
Ausonia Farma Srl |
COMPOUND WITH ANALGESIC, ANTI-INFLAMMATORY AND MUCOREGULATING ACTIVITY PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
|
FR2528038B2
(en)
|
1982-06-04 |
1985-08-09 |
Lafon Labor |
BENZHYDRYLSULFINYLACETAMIDE DERIVATIVES AND THEIR THERAPEUTIC USE
|
US4564628A
(en)
|
1983-01-03 |
1986-01-14 |
Nelson Research & Development Co. |
Substituted 2-aminotetralins
|
US5104887A
(en)
|
1983-02-04 |
1992-04-14 |
University Of Iowa Research Foundation |
Topical ophthalmic imino substituted 2-imino-3-methyl-delta4-1,3,4-thiadiazoline-5-sulfonamides carbonic anhydrase inhibitors
|
AU560367B2
(en)
|
1983-08-01 |
1987-04-02 |
Astra Lakemedel Aktiebolag |
L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
|
JPS6089474A
(en)
|
1983-10-20 |
1985-05-20 |
Toyo Pharma- Kk |
Morphinan derivative, production thereof and antitumor agent containing said compound
|
IL73293A
(en)
|
1983-11-04 |
1988-02-29 |
Abbott Lab |
Methyl 2-(alkanamidoalkylsulfonic)ethylthiophosphonate derivatives
|
IT1213132B
(en)
|
1984-02-02 |
1989-12-14 |
Yason Srl |
ANTIBRONCOPNEUMOPATHIC AGENT.
|
US4550109A
(en)
|
1984-05-31 |
1985-10-29 |
The Board Of Regents, The University Of Texas System |
Lipoidal biopterin compounds
|
CH664150A5
(en)
*
|
1985-01-15 |
1988-02-15 |
Peter Paul Prof Dr Speiser |
FUMARIC ACID PRODUCT, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL FORMS CONTAINING THIS.
|
US5149695A
(en)
*
|
1985-01-15 |
1992-09-22 |
Speiser Peter P |
Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
|
JPS61277618A
(en)
|
1985-06-04 |
1986-12-08 |
Suntory Ltd |
Remedy for autism
|
YU213587A
(en)
|
1986-11-28 |
1989-06-30 |
Orion Yhtymae Oy |
Process for obtaining new pharmacologic active cateholic derivatives
|
US4873259A
(en)
|
1987-06-10 |
1989-10-10 |
Abbott Laboratories |
Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
|
US5080646A
(en)
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5102870A
(en)
|
1989-04-14 |
1992-04-07 |
Schering Ag |
Treatment and prevention of oral mucositis with growth factors
|
DE69016335T2
(en)
|
1989-10-06 |
1995-06-01 |
Fujirebio Kk |
Pantothenic acid derivatives.
|
US5242937A
(en)
|
1990-03-19 |
1993-09-07 |
Research Corporation Technologies, Inc. |
Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
|
IT1248702B
(en)
|
1990-06-06 |
1995-01-26 |
Yason Srl |
ANTITUSSIVE AGENT AND MUCOREGULATOR, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS
|
FR2699077B1
(en)
|
1992-12-16 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Application of anticonvulsants in the treatment of neurological lesions linked to trauma.
|
FR2707637B1
(en)
|
1993-06-30 |
1995-10-06 |
Lafon Labor |
New acetamide derivatives, their preparation process and their use in therapy.
|
WO1995022546A1
(en)
|
1994-02-18 |
1995-08-24 |
Cell Therapeutics, Inc. |
Intracellular signalling mediators
|
SE9401727D0
(en)
|
1994-05-18 |
1994-05-18 |
Astra Ab |
New compounds I
|
FR2722199B3
(en)
|
1994-07-11 |
1996-09-06 |
Univ Picardie Jules Verne Etab |
VALPROIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MEDICAMENTS
|
US6156777A
(en)
|
1994-12-15 |
2000-12-05 |
Pharmacia & Upjohn Company |
Use of pramipexole as a neuroprotective agent
|
IL113459A
(en)
|
1995-04-23 |
2000-07-16 |
Electromagnetic Bracing System |
Electrophoretic cuff apparatus
|
US6239180B1
(en)
|
1995-11-08 |
2001-05-29 |
The Regents Of The University Of California |
Transdermal therapeutic device and method with capsaicin and capsaicin analogs
|
NZ334389A
(en)
|
1996-08-28 |
2001-05-25 |
Ube Industries |
Cyclic amine derivatives
|
FR2756285B1
(en)
|
1996-11-22 |
1998-12-18 |
Synthelabo |
N- (IMIDAZOLYLBUTYL) BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
|
TR199901603T2
(en)
|
1996-11-22 |
2000-02-21 |
Elan Pharmaceuticals, Inc. |
To inhibit the release and/or synthesis of β-amyloid peptide using N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions containing them, and such compounds for methods.
|
US6414008B1
(en)
|
1997-04-29 |
2002-07-02 |
Boehringer Ingelheim Pharma Kg |
Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
|
GB9710351D0
(en)
|
1997-05-20 |
1997-07-16 |
Scotia Holdings Plc |
Glucosamine fatty acids
|
EP0968711B9
(en)
|
1997-10-28 |
2008-05-28 |
Bando Chemical Industries, Ltd. |
Dermatological patch sheet and process for producing base sheet therefor
|
NZ333474A
(en)
|
1998-01-02 |
1999-06-29 |
Mcneil Ppc Inc |
A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
|
HU225741B1
(en)
|
1998-02-27 |
2007-07-30 |
Ube Industries |
Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
|
JP3761324B2
(en)
|
1998-05-15 |
2006-03-29 |
ヤンマー農機株式会社 |
Passenger rice transplanter
|
US6103275A
(en)
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
DE19827732A1
(en)
|
1998-06-22 |
1999-12-23 |
Rottapharm Bv |
Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
|
US6846495B2
(en)
|
1999-01-11 |
2005-01-25 |
The Procter & Gamble Company |
Compositions having improved delivery of actives
|
PL350924A1
(en)
|
1999-04-06 |
2003-02-10 |
Sepracor Inc |
Derivatives of venlafaxine and methods of preparing and using the same
|
US6312716B1
(en)
|
1999-05-10 |
2001-11-06 |
Peierce Management Llc |
Patch and method for transdermal delivery of bupropion base
|
US6262118B1
(en)
|
1999-06-04 |
2001-07-17 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
|
CZ2002947A3
(en)
|
1999-09-29 |
2002-08-14 |
The Procter & Gamble Company |
Liquid preparation, most preferably oral preparation with enhanced stability and process of its preparation
|
US6974588B1
(en)
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
WO2001092283A2
(en)
|
2000-05-31 |
2001-12-06 |
Mayo Foundation For Medical Education And Research |
Cobalamin compounds useful as cardiovascular agents and as imaging agents
|
US6429223B1
(en)
|
2000-06-23 |
2002-08-06 |
Medinox, Inc. |
Modified forms of pharmacologically active agents and uses therefor
|
WO2002009769A2
(en)
|
2000-07-27 |
2002-02-07 |
Rutgers, The State University Of New Jersey |
Therapeutic azo-compounds for drug delivery
|
BR0114846A
(en)
|
2000-10-24 |
2004-02-25 |
Ajinomoto Kk |
Method for Producing Nateglinide Type B Crystals Substantially Free of Type H Crystals
|
DE10103506A1
(en)
|
2001-01-26 |
2002-08-14 |
Ingo S Neu |
Pharmaceutical composition for the treatment of multiple sclerosis
|
UA81224C2
(en)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Dosage form of oxycodone and use thereof
|
FR2827517B1
(en)
|
2001-07-23 |
2003-10-24 |
Bioalliance Pharma |
EXTENDED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS
|
AU2002326806B2
(en)
|
2001-08-29 |
2007-07-19 |
Endo Pharmaceuticals, Inc. |
Analgetic pyrroline derivatives
|
US7138133B2
(en)
|
2001-10-10 |
2006-11-21 |
The Procter & Gamble Company |
Orally administered liquid compositions
|
US20040010038A1
(en)
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
US20030220344A1
(en)
|
2002-04-04 |
2003-11-27 |
Luiz Belardinelli |
Method of treating arrhythmias
|
CA2482669A1
(en)
|
2002-04-15 |
2003-10-23 |
Novartis Ag |
Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
|
WO2003086391A1
(en)
|
2002-04-16 |
2003-10-23 |
Fujisawa Pharmaceutical Co., Ltd. |
New use
|
US7060725B2
(en)
|
2002-05-13 |
2006-06-13 |
Janssen Pharmaceutica N.V. |
Substituted sulfamate anticonvulsant derivatives
|
GB0223224D0
(en)
|
2002-10-07 |
2002-11-13 |
Novartis Ag |
Organic compounds
|
WO2004052841A1
(en)
|
2002-12-06 |
2004-06-24 |
Xenoport, Inc. |
Carbidopa prodrugs and uses thereof
|
PT1988397E
(en)
|
2002-12-19 |
2011-12-02 |
Scripps Research Inst |
Compositions and uses for stabilising transthyretin and inhibiting transthyretin misfolding
|
EP1908461B9
(en)
|
2003-02-14 |
2011-08-31 |
Pierre Fabre Medicament |
Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine
|
UA81657C2
(en)
|
2003-03-04 |
2008-01-25 |
Орто-Макнейл Фармасьютикел, Инк. |
Normal;heading 1;heading 2;PROCESS FOR THE PREPARATION OF ANTICONVULSANT DERIVATIVES OF TOPIRAMATE
|
RU2356247C2
(en)
|
2003-03-18 |
2009-05-27 |
Новартис Аг |
Combinations and compositions containing fatty acids and amino acids, their application for prevention and delay of progressing or treatment of diabetes and diabetes associated diseases and conditions, method of weight reduction in mammal, kit
|
EP1643999B8
(en)
|
2003-06-20 |
2012-03-14 |
NephroGenex, Inc. |
Pyridoxamine for use in the treatment of diabetic nephropathy in type ii diabetes
|
NZ601772A
(en)
|
2003-07-29 |
2012-10-26 |
Signature R & D Holdings Llc |
Amino Acid Prodrugs
|
PL1677767T3
(en)
|
2003-10-14 |
2011-12-30 |
Xenoport Inc |
Crystalline form of gamma-aminobutyric acid analog
|
US7470435B2
(en)
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
TW200526624A
(en)
|
2003-11-28 |
2005-08-16 |
Sankyo Co |
Cyclic aryl derivatives containing with heteroaryl ring
|
DE10361259A1
(en)
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Use of Rotigotine in Early Stage Parkinson's Disease to Prevent Further Neuronal Loss
|
CN1248690C
(en)
|
2004-03-25 |
2006-04-05 |
华中师范大学 |
Oral preparation containing ranolazine hydrochloride for treating cardiovascular disease
|
EP1742534A4
(en)
|
2004-04-07 |
2011-04-13 |
Univ Georgia |
Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
|
EP1740162A4
(en)
|
2004-04-29 |
2009-11-18 |
Caldwell Galer Inc |
Topical methadone compositions and methods for using the same
|
CN1672678A
(en)
|
2004-05-03 |
2005-09-28 |
深圳微芯生物科技有限责任公司 |
Separation and extraction of natural active long-chain fatty acid component for preventing and treating prostatosis and the prepn and application of its medicine prepn
|
MX339690B
(en)
|
2004-06-04 |
2016-06-06 |
Xenoport Inc |
Levodopa prodrugs, and compositions and uses thereof.
|
CN100455560C
(en)
|
2004-06-09 |
2009-01-28 |
中国人民解放军军事医学科学院放射医学研究所 |
Medicine precursor containing long chain fatty acyl group substituted venlafaxine and its prepn and use
|
EP1845942B1
(en)
|
2005-01-14 |
2014-04-09 |
Camurus Ab |
Gnrh analogue formulations
|
EP1863433A4
(en)
|
2005-03-18 |
2009-09-09 |
Ripped Formulations Ltd |
Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
|
US20080221111A1
(en)
|
2005-05-11 |
2008-09-11 |
Nycomed Gmbh |
Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative
|
DE102005022276A1
(en)
|
2005-05-13 |
2006-11-16 |
Ellneuroxx Ltd. |
Derivatives of dihydroxyphenylalanine
|
AU2006250335B2
(en)
|
2005-05-27 |
2010-09-02 |
Daiichi Sankyo Company, Limited |
Cyclic amine derivative having substituted alkyl group
|
WO2006125293A1
(en)
|
2005-05-27 |
2006-11-30 |
Antibe Therapeutics Inc. |
Derivatives of 4- or 5-aminosalicylic acid
|
US20060270635A1
(en)
|
2005-05-27 |
2006-11-30 |
Wallace John L |
Derivatives of 4- or 5-aminosalicylic acid
|
CA2626249A1
(en)
|
2005-10-18 |
2007-04-26 |
Boehringer Ingelheim International Gmbh |
Use of pramipexol for treating moderate to severe restless legs syndrome (rls)
|
EP1980271A4
(en)
|
2006-01-27 |
2012-04-25 |
Asahi Kasei Pharma Corp |
Medicine for transnasal administration
|
US20070259930A1
(en)
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
EP1870395A1
(en)
|
2006-06-19 |
2007-12-26 |
KRKA, D.D., Novo Mesto |
Process for preparation of o-desmethylvenlafaxine and its analogue
|
US7943666B2
(en)
|
2006-07-24 |
2011-05-17 |
Trinity Laboratories, Inc. |
Esters of capsaicin for treating pain
|
US7645767B2
(en)
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
TW200817048A
(en)
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
CN102772404A
(en)
|
2006-12-14 |
2012-11-14 |
诺普神经科学股份有限公司 |
Compositions of (r)-pramipexole and methods of using the same
|
CN100573950C
(en)
|
2006-12-14 |
2009-12-23 |
财团法人工业技术研究院 |
Phase change memory apparatus and manufacture method thereof
|
WO2008079404A2
(en)
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
CA2675134A1
(en)
|
2007-01-12 |
2008-07-24 |
Biomarin Pharmaceutical Inc. |
Pterin analogs
|
ES2319024B1
(en)
|
2007-02-13 |
2009-12-11 |
Quimica Sintetica, S.A. |
PROCEDURE FOR OBTAINING ENTACAPONA SUBSTANTIALLY FREE OF ISOMERO Z, ITS SYNTHESIS INTERMEDIATES AND NEW CRYSTAL FORM.
|
CA2681110A1
(en)
|
2007-03-14 |
2008-09-18 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
EP2152709B1
(en)
|
2007-05-01 |
2012-02-22 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
EP1997493A1
(en)
|
2007-05-28 |
2008-12-03 |
Laboratorios del Dr. Esteve S.A. |
Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
|
WO2009002297A1
(en)
|
2007-06-22 |
2008-12-31 |
Gluconova Llc |
Halide-free glucosamine-acidic drug complexes
|
US20090075942A1
(en)
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fosamprenavir
|
CN101390854A
(en)
|
2007-09-21 |
2009-03-25 |
北京德众万全药物技术开发有限公司 |
Medical composition containing riluzole
|
WO2009056791A1
(en)
|
2007-11-02 |
2009-05-07 |
Pliva Hrvatska D.O.O. |
Processes for preparing pharmaceutical compounds
|
TW200936123A
(en)
|
2007-11-06 |
2009-09-01 |
Xenoport Inc |
Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
|
CN101186583B
(en)
|
2007-12-20 |
2011-05-11 |
吉林大学 |
Methyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate and its synthesizing method and application
|
US20100081713A1
(en)
|
2008-03-19 |
2010-04-01 |
CombinatoRx, (Singapore) Pte. Ltd. |
Compositions and methods for treating viral infections
|
CN101569618B
(en)
|
2008-04-30 |
2011-11-09 |
上海医药工业研究院 |
Application of long-chain fatty acid derivative or plant extracts containing same in inhibiting the activity of aromatizing enzyme
|
KR100990949B1
(en)
|
2008-06-09 |
2010-10-29 |
엔자이텍 주식회사 |
Method for Preparing Clopidogrel and Derivatives Thereof
|
KR101708065B1
(en)
|
2008-07-08 |
2017-02-17 |
카타베이시스 파마슈티칼즈, 인코포레이티드 |
Fatty acid acetylated salicylates and their uses
|
CN102123763B
(en)
|
2008-08-19 |
2014-10-08 |
什诺波特有限公司 |
Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
|
NZ591326A
(en)
|
2008-08-22 |
2012-12-21 |
Wockhardt Research Center |
An extended release pharmaceutical composition of entacapone or salts thereof
|
EP2165706A1
(en)
|
2008-09-18 |
2010-03-24 |
BioAlliance Pharma |
Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
|
WO2010073124A2
(en)
|
2008-12-26 |
2010-07-01 |
Actavis Group Ptc Ehf |
Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
|
BRPI0901298A2
(en)
|
2009-04-06 |
2011-01-04 |
Ems Sa |
phthalimide derivatives of nonsteroidal antiinflammatory compounds and / or modulators of tnf- (alpha), process for obtaining them, pharmaceutical compositions containing them and their uses in the treatment of inflammatory diseases
|
NZ771180A
(en)
|
2009-04-29 |
2022-07-29 |
Amarin Pharmaceuticals Ie Ltd |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
WO2010147666A1
(en)
|
2009-06-19 |
2010-12-23 |
Memorial Sloan-Kettering Cancer Center |
Compounds useful as carbonic anhydrase modulators and uses thereof
|
NZ598085A
(en)
|
2009-08-10 |
2014-02-28 |
Bhi Ltd Partnership |
Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
|
CN102002053A
(en)
|
2009-09-02 |
2011-04-06 |
陕西合成药业有限公司 |
Tetrahydro thienopyridine derivative for treating
|
CN101717392A
(en)
|
2009-10-09 |
2010-06-02 |
苏州凯达生物医药技术有限公司 |
Method for preparing rotigotine and derivative thereof
|
CN102050815B
(en)
|
2009-11-06 |
2014-04-02 |
北京美倍他药物研究有限公司 |
Dabigatran ester derivatives as prodrug
|
CN101724934B
(en)
|
2009-11-10 |
2012-07-04 |
东华大学 |
Medicinal fibre used for treating cutaneous inflammation and pain, preparation and application thereof
|
ES2364011B1
(en)
|
2009-11-20 |
2013-01-24 |
Gp Pharm, S.A. |
CAPSULES OF PHARMACEUTICAL ACTIVE AND ESTERS OF POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
|
WO2011085211A1
(en)
|
2010-01-08 |
2011-07-14 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid fumarate derivatives and their uses
|
US9062094B2
(en)
|
2010-01-22 |
2015-06-23 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
RU2436772C2
(en)
|
2010-01-28 |
2011-12-20 |
Закрытое акционерное общество "НПК ЭХО" |
4[(4'-nicotinoylamino)butyroylamino]butanoic acid, exhibiting nootropic activity, and method of producing said compound
|
US20130190327A1
(en)
|
2010-02-26 |
2013-07-25 |
Catabasis Pharmaceuticals Inc |
Bis-fatty acid conjugates and their uses
|
JP5412340B2
(en)
|
2010-03-19 |
2014-02-12 |
本田技研工業株式会社 |
Vehicle viewing window
|
CA2801336C
(en)
|
2010-06-08 |
2020-01-28 |
Mahesh Kandula |
Cysteamine derivatives and their use in the treatment of nash
|
US9220693B2
(en)
|
2010-07-12 |
2015-12-29 |
Boehringer Ingelheim International Gmbh |
Aqueous composition comprising bromhexine
|
WO2012025213A2
(en)
|
2010-08-23 |
2012-03-01 |
Grünenthal GmbH |
Novel therapeutic compounds
|
WO2012027543A1
(en)
|
2010-08-25 |
2012-03-01 |
Teva Pharmaceuticals Usa, Inc. |
Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
|
CN101921245B
(en)
|
2010-08-30 |
2012-04-18 |
中国人民解放军军事医学科学院卫生学环境医学研究所 |
Sulfonamides compound for inhibiting carbonic anhydrase II and synthesis method and application thereof
|
PL2632451T3
(en)
|
2010-10-29 |
2018-04-30 |
Algiax Pharmaceuticals Gmbh |
Use of malononitrilamides in neuropathic pain
|
EP2450039A1
(en)
|
2010-11-08 |
2012-05-09 |
PAION UK Ltd. |
Dosing regimen for sedation with CNS 7056 (Remimazolam)
|
WO2012115695A1
(en)
|
2011-02-25 |
2012-08-30 |
Catabasis Pharmaceuticals, Inc. |
Bis-fatty acid conjugates and their uses
|
WO2013008182A1
(en)
|
2011-07-10 |
2013-01-17 |
Mahesh Kandula |
Prodrugs of gaba analogs
|
CN102336767A
(en)
|
2011-07-11 |
2012-02-01 |
华东理工大学 |
Method for preparing high-purity chiral alpha-substituted-6,7-thiaindan[3,2-c]pyridine derivative
|
WO2013017974A1
(en)
|
2011-07-30 |
2013-02-07 |
Mahesh Kandula |
Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases
|
WO2013024376A1
(en)
|
2011-08-16 |
2013-02-21 |
Mahesh Kandula |
Compositions and methods for the treatment of atherothrombosis
|
WO2013027150A1
(en)
|
2011-08-21 |
2013-02-28 |
Mahesh Kandula |
Compositions and methods for the treatment of parkinson's disease
|
CN102633799B
(en)
|
2012-04-10 |
2014-06-25 |
凯莱英医药集团(天津)股份有限公司 |
Method for synthesizing sapropterin dihydrochloride from racemate intermediate separation route
|
WO2013167988A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of cough
|
WO2013168022A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treating atherothrombosis
|
WO2013167993A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological degenerative disorders
|
CN104603090A
(en)
|
2012-05-10 |
2015-05-06 |
塞利克斯比奥私人有限公司 |
Compositions and methods for the treatment of metabolic syndrome
|
CA2873098A1
(en)
*
|
2012-05-23 |
2013-11-28 |
Cellixbio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
AU2013264820A1
(en)
|
2012-05-23 |
2014-11-27 |
Cellixbio Private Limited |
Compositions and methods for treatment of mucositis
|
WO2014087323A2
(en)
*
|
2012-12-06 |
2014-06-12 |
Mahesh Kandula |
Compositions and methods for the treatment of autoimmune and chronic metabolic diseases
|
WO2014174425A2
(en)
|
2013-04-24 |
2014-10-30 |
Mahesh Kandula |
Compositions and methods for the treatment of orthostasis and neurological diseases
|
CA2914461A1
(en)
|
2013-06-04 |
2014-12-11 |
Cellixbio Private Limited |
Compositions and methods for the treatment of diabetes and pre-diabetes
|